Overview

Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
10 healthy men will be PET-scanned (CNS) twice in random order with infusions of placebo or Native GLP-1 during hyperglycemic clamp to uncover the metabolic effects of GLP-1 in perspectives of intervention of macrovascular late diabetic pathology such as stroke and AMI. Earlier studies have revealed tendencies towards steady glucose metabolism in the CNS despite fluctuations in blood sugar when infusing native GLP-1.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Aarhus
Treatments:
Glucagon
Glucagon-Like Peptide 1